Pulmonary Deposition of Radionucleotide-Labeled Palivizumab: Proof-of-Concept Study

• Principais autores: Anushi E. Rajapaksa (Autor), Lien Anh Ha Do (Autor), Darren Suryawijaya Ong (Autor), Magdy Sourial (Autor), Duncan Veysey (Autor), Richard Beare (Autor), William Hughes (Autor), William Yang (Autor), Robert J. Bischof (Autor), Amarin McDonnell (Autor), Peter Eu (Autor), Leslie Y. Yeo (Autor), Paul V. Licciardi (Autor), Edward K. Mulholland (Autor)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2020-08-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

ObjectiveCurrent prevention and/or treatment options for respiratory syncytial virus (RSV) infections are limited as no vaccine is available. Prophylaxis with palivizumab is very expensive and requires multiple intramuscular injections over the RSV season. Here we present proof-of-concept data using...